...
【24h】

Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy

机译:PET扫描在术前放疗后腹膜后肉瘤患者中的价值

获取原文
获取原文并翻译 | 示例

摘要

Purpose: Preoperative radiotherapy provides advantages in the management of retroperitoneal sarcoma (RPS). We describe our experience treating a cohort who underwent pre- and post-radiotherapy functional imaging with FDG-PET scan. Methods and materials: Consecutive patients presenting between January 1999 and December 2009 with a diagnosis of either primary or recurrent RPS were identified from the hospital patient record database using ICD codes, and cross-referenced with the completed radiotherapy course database. Those patients suitable for preoperative radiotherapy and surgery who underwent both pre- and post-radiotherapy FDG-PET were included. Exclusions included presence of metastatic disease, age under 18 years and/or paediatric histology, and treatment with palliative intent. Results: Eleven patients were included, of whom six were male. Median age was 63 years (range, 38-78 years). The majority of patients had Stage T2b, high-grade disease. Ten patients were treated at initial presentation and one at first local recurrence. A malignant diagnosis was confirmed in all patients who underwent CT-guided core biopsy; a diagnosis of sarcoma was reached in 91%. Sensitivity of FDG-PET imaging was 100%. Metabolic partial or complete response did not correlate with change in tumour size, nor pathological response assessment. Pulmonary and hepatic metastatic disease was detected in one patient on post-treatment imaging. All patients in the cohort completed preoperative radiotherapy. There was no grade 3 or 4 toxicity. Sixty-four percent proceeded to radical resection. Complete macroscopic excision was achieved in all cases. There was no perioperative mortality. Conclusion: Combined therapy with preoperative radiotherapy and surgery has acceptable levels of toxicity. CT-guided core biopsy is an accurate means of confirming a diagnosis of RPS prior to definitive treatment. Utility of PET scan in the management of RPS is evolving and further investigation is warranted.
机译:目的:术前放疗在腹膜后肉瘤(RPS)的治疗中提供优势。我们描述了我们对接受FDG-PET扫描放射治疗前后功能成像的队列研究的经验。方法和材料:使用ICD代码从住院患者病历数据库中识别出1999年1月至2009年12月间诊断为原发性或复发性RPS的连续患者,并与完整的放射治疗课程数据库进行交叉引用。纳入了适合术前放疗和手术的患者,在放疗前和放疗后均接受了FDG-PET。排除包括转移性疾病的存在,18岁以下的儿童和/或儿科组织学以及姑息性治疗。结果:共纳入11例患者,其中6例为男性。中位年龄为63岁(范围为38-78岁)。大多数患者患有T2b期高度疾病。初次就诊时治疗10例患者,第一次局部复发时治疗1例。在所有接受CT引导的核心活检的患者中均确认为恶性诊断。肉瘤的诊断率为91%。 FDG-PET成像的灵敏度为100%。代谢的部分或完全反应与肿瘤大小的变化无关,也与病理反应评估无关。在治疗后的影像学中检测到一名患者的肺和肝转移性疾病。该队列中的所有患者均已完成术前放疗。没有3级或4级毒性。百分之六十四进行了彻底切除。在所有情况下都可以完成宏观切除。没有围手术期死亡率。结论:术前放疗与手术相结合的治疗具有可接受的毒性水平。 CT引导的核心活检是在明确治疗之前确认RPS诊断的准确方法。 PET扫描在RPS管理中的用途正在不断发展,因此有必要进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号